Read More Pharma Industry News Humanigen announces positive interim results for lenzilumab in COVID-19 phase 3 trial Humanigen, a U.S.-based biopharmaceutical company, has revealed promising interim data from its phase 3 clinical trial of lenzilumab,… bypharmanewsdailyNovember 8, 2020
